{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T11:07:35Z","timestamp":1791544055787,"version":"4.3.4"},"reference-count":6,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Asian Journal of Psychiatry"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.ajp.2017.02.015","type":"journal-article","created":{"date-parts":[[2017,2,21]],"date-time":"2017-02-21T04:00:45Z","timestamp":1487649645000},"page":"67-68","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Aripiprazole and impulse-control disorders in high-risk patients"],"prefix":"10.1016","volume":"27","author":[{"given":"Titus","family":"Mohan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Dolan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riche","family":"Mohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Dawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajp.2017.02.015_bib0005","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"2013"},{"issue":"3","key":"10.1016\/j.ajp.2017.02.015_bib0010","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.addbeh.2013.11.005","article-title":"Aripiprazole: a new risk factor for pathological gambling? A report of 8 case reports","volume":"39","author":"Gaboriau","year":"2014","journal-title":"Addict. Behav."},{"issue":"161","key":"10.1016\/j.ajp.2017.02.015_bib0015","article-title":"Recent methods for measuring dopamine D3 receptor occupancy in vivo: importance for drug development","volume":"5","author":"Le Foll","year":"2014","journal-title":"Front. Pharmacol."},{"issue":"2016","key":"10.1016\/j.ajp.2017.02.015_bib0020","first-page":"7","article-title":"Deficient inhibitory control as an outcome of childhood trauma","volume":"235","author":"Marshall","year":"2015","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.ajp.2017.02.015_bib0025","series-title":"Stahl\u2019s Essential Psychopharmacology: Neuroscientific Basis and Practical Applications","author":"Stahl","year":"2013"},{"key":"10.1016\/j.ajp.2017.02.015_bib0030","unstructured":"US Food and Drug Association, 2016. FDA Drug Safety Communication: FDA warns about new impulse-control problems associated with mental health drug aripiprazole (Abilify, Abilify Maintena, Aristada). Available at: www.fda.gov\/Drugs\/DrugSafety\/ucm498662. htm (Accessed 9 June 2016)."}],"container-title":["Asian Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876201817300928?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876201817300928?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T16:27:50Z","timestamp":1761755270000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876201817300928"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":6,"alternative-id":["S1876201817300928"],"URL":"https:\/\/doi.org\/10.1016\/j.ajp.2017.02.015","relation":{},"ISSN":["1876-2018"],"issn-type":[{"value":"1876-2018","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aripiprazole and impulse-control disorders in high-risk patients","name":"articletitle","label":"Article Title"},{"value":"Asian Journal of Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajp.2017.02.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2017 Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}